|
|
||||||||
MUCOSAL BIOLOGY
Gastroenterology and Nutrition Laboratory, Biomedical Center B11, Lund University Hospital, S-22184 Lund, Sweden
Submitted 7 April 2004 ; accepted in final form 28 May 2004
Neutral ceramidase activity has previously been identified in the intestinal mucosa and gut lumen and postulated to be important in the digestion of sphingolipids. It is found throughout the intestine but has never been fully characterized. We have purified rat intestinal neutral ceramidase from an eluate obtained by perfusing the intestinal lumen with 0.9% NaCl and 3 mM sodium taurodeoxycholate. Using a combination of acetone precipitation and ion-exchange, hydrophobic-interaction, and gel chromatographies, we obtained a homogenous enzyme protein with a molecular mass of
116 kDa. The enzyme acts on both [14C]octanoyl- and [14C]palmitoyl-sphingosine in the presence of glycocholic and taurocholic acid and the bile salt analog 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate but is inhibited by 2 mM or more of other bile salts. It is a glycosylated protein stable to trypsin and chymotrypsin exposure, is not influenced by Ca2+, Mg2+, or Mn2+, and is inhibited by Zn2+ and Cu2+. Mass fragmentographic analysis identified 12 fragments covering 17.5% of the sequence for neutral/alkaline ceramidase 2 purified (Mitsutake S, Tani M, Okino N, Mori K, Ichinose S, Omori A, Iida H, Nakamura T, and Ito M. J Biol Chem 276: 26249262459, 2001) from rat kidney and located in apical membrane of renal tubular cells. Intestinal and kidney ceramidases also have similar molecular mass and ion dependence. Intestinal ceramidase thus is a neutral ceramidase 2 released by bile salts and resistant to pancreatic proteases. It is well suited to metabolize ceramide formed from dietary and brush border sphingolipids to generate other bioactive sphingolipid messengers.
bile salt; intestine; mass spectrometry; octanoyl-sphingosine; palmitoyl-sphingosine
. Nilsson, Dept. of Medicine, Gastroenterology and Nutrition Laboratory, BMC B11, Lund Univ. Hospital, S-22184 Lunds Universitet, Sweden (E-mail: Ake.nilsson{at}med.lu.se)This article has been cited by other articles:
![]() |
B. X. Wu, C. F. Snook, M. Tani, E. E. Bullesbach, and Y. A. Hannun Large-scale purification and characterization of recombinant Pseudomonas ceramidase: regulation by calcium J. Lipid Res., March 1, 2007; 48(3): 600 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Houben, W. M. Holleran, T. Yaginuma, C. Mao, L. M. Obeid, V. Rogiers, Y. Takagi, P. M. Elias, and Y. Uchida Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis J. Lipid Res., May 1, 2006; 47(5): 1063 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nilsson and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J. Lipid Res., January 1, 2006; 47(1): 154 - 171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |